BioLife Solutions
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 48.1m | 119m | 162m | 143m | 110m | 119m | 155m |
% growth | 76 % | 148 % | 36 % | (11 %) | (23 %) | 8 % | 31 % |
EBITDA | (3.0m) | (24.0m) | (29.5m) | (37.1m) | 13.7m | 24.6m | 41.3m |
% EBITDA margin | (6 %) | (20 %) | (18 %) | (26 %) | 13 % | 21 % | 27 % |
Profit | 2.7m | (8.4m) | (140m) | (66.4m) | (26.0m) | (10.6m) | 7.6m |
% profit margin | 6 % | (7 %) | (86 %) | (46 %) | (24 %) | (9 %) | 5 % |
EV / revenue | 25.3x | 13.0x | 4.8x | 5.1x | 10.9x | 10.0x | 7.7x |
EV / EBITDA | -408.3x | -64.7x | -26.4x | -19.8x | 86.9x | 48.6x | 28.9x |
R&D budget | 6.7m | 11.8m | 14.8m | 18.8m | - | - | - |
R&D % of revenue | 14 % | 10 % | 9 % | 13 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
N/A | $2.6m | Post IPO Equity | |
* | N/A | $86.0m | Post IPO Equity |
* | $262k | Post IPO Equity | |
* | $10.4m | Private Placement non VC | |
Total Funding | - |
Related Content
Recent News about BioLife Solutions
EditBioLife Solutions, Inc. specializes in biopreservation technology, providing advanced products designed to enhance the viability and functionality of cells and tissues used in clinical applications. The company serves clients in the biotechnology, pharmaceutical, and regenerative medicine sectors, offering a range of products including cryopreservation media, automated vial filling systems, and fluid management systems. Operating in the global market, BioLife Solutions generates revenue through the sale of its proprietary biopreservation media and related products, which are critical for the storage and transport of biological materials. The business model focuses on continuous innovation and collaboration with industry leaders to meet the evolving needs of cell and gene therapy developers. Key clients include research institutions, pharmaceutical companies, and biotech firms engaged in cell therapy and regenerative medicine. BioLife Solutions' commitment to quality and innovation positions it as a leader in the biopreservation industry.
Keywords: biopreservation, cryopreservation, cell therapy, gene therapy, regenerative medicine, biotechnology, pharmaceutical storage, fluid management, automated vial filling, clinical applications.